Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- HUF 1697.75T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | HUF 3.35T | HUF 22,189.14 | 5.44% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | HUF 2.77T | HUF 39,948.51 | 2.08% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | HUF 1.59T | HUF 28,182.76 | 3.45% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | HUF 2.79T | HUF 42,673.50 | 2.00% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | HUF 2.86T | HUF 102,418.41 | 0.04% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | HUF 2.4T | HUF 17,222.43 | 0.64% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | HUF 1.53T | HUF 9,191.78 | 1.59% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | HUF 2.01T | HUF 100,243.79 | 1.67% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | HUF 3.23T | HUF 34,048.86 | 8.15% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | HUF 2.64T | HUF 15,722.34 | 3.08% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | HUF 1.52T | HUF 13,883.32 | 1.59% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | HUF 5.1T | HUF 26,179.30 | 1.58% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | HUF 1.62T | HUF 4,617.70 | 0.94% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | HUF 1.62T | HUF 9,332.73 | 0.14% down | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | HUF 2.03T | HUF 31,038.63 | 0.59% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | HUF 1.62T | HUF 16,859.99 | 1.68% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | HUF 2.18T | HUF 32,129.29 | 0.60% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | HUF 1.69T | HUF 20,212.53 | 0.22% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | HUF 3.1T | HUF 133,591.27 | 5.67% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | HUF 5.34T | HUF 83,148.89 | 2.93% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | HUF 2.49T | HUF 22,749.58 | 3.25% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | HUF 2.05T | HUF 14,467.24 | 0.28% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | HUF 1.77T | HUF 41,901.64 | 0.62% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | HUF 3.99T | HUF 20,615.23 | 4.99% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | HUF 1.34T | HUF 9,772.35 | 0.88% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | HUF 4.48T | HUF 8,960.23 | 3.29% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | HUF 8.82T | HUF 40,203.56 | 1.69% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | HUF 9.42T | HUF 12,997.36 | 0.05% up | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | HUF 2.37T | HUF 44,968.93 | 1.43% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | HUF 1.06T | HUF 5,453.32 | 0.87% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | HUF 2.51T | HUF 31,897.73 | 0.06% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | HUF 2.82T | HUF 3,523.68 | 1.59% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | HUF 2.46T | HUF 28,132.43 | 2.11% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | HUF 5.95T | HUF 90,719.77 | 0.32% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | HUF 8.25T | HUF 193,748.95 | 1.16% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | HUF 11.67T | HUF 28,716.35 | 2.50% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | HUF 6.72T | HUF 50,137.00 | 4.54% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | HUF 2.13T | HUF 52,429.07 | 0.94% down | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | HUF 2.56T | HUF 7,342.69 | 3.60% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | HUF 7.8T | HUF 6,805.74 | 0.83% down | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | HUF 4.19T | HUF 5,027.12 | 1.28% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | HUF 16.54T | HUF 14,171.92 | 0.92% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | HUF 53.67T | HUF 9,416.63 | 1.44% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | HUF 40.86T | HUF 19,987.68 | 2.92% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | HUF 13.25T | HUF 23,044.90 | 0.01% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | HUF 32.82T | HUF 317,309.47 | 1.28% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | HUF 45.64T | HUF 180,026.72 | 0.42% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | HUF 10.55T | HUF 17,104.97 | 1.91% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | HUF 15.47T | HUF 135,443.72 | 2.34% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | HUF 60.73T | HUF 35,062.34 | 0.22% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | HUF 113.99T | HUF 46,237.45 | 3.90% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | HUF 169.66T | HUF 95,981.81 | 2.33% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | HUF 1.93T | HUF 2,842.44 | 1.85% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | HUF 58.32T | HUF 13,232.27 | 3.12% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | HUF 413.34T | HUF 464,035.69 | 2.32% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | HUF 32.68T | HUF 16,302.91 | 1.34% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | HUF 220.31T | HUF 91,515.12 | 2.15% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | HUF 37.97T | HUF 15,812.95 | 0.86% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | HUF 98.37T | HUF 52,086.77 | 2.46% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | HUF 93.04T | HUF 59,989.89 | 1.93% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | HUF 22.81T | HUF 7,137.98 | 1.71% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 335.6 HUF).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of HUF 1697.75T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.